Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michel Reynaud

Showing results (41-50 of 102) with videos related to

Pageof 11
Sort By:
La Revue Du Praticien|June 27, 2012
[Synthetic drugs: the new low-cost landscape of drugs]Laurent Karila, Aymeric Petit, Olivier Cottencin, et al.
La Revue Du Praticien|June 27, 2012
[Energy drinks: an unknown risk]Aymeric Petit, Fanny Levy, Michel Lejoyeux, et al.
The American Journal on Addictions|December 7, 2007
Intravenous zolpidem abuse: a case for serotonin depletionAmine Benyamina, Olivier Dublanchet, Laurent Karila, et al.
Presse Medicale (Paris, France : 1983)|February 17, 2012
[Addiction to cocaine: a risk factor for suicide?]Aymeric Petit, Michel Reynaud, Michel Lejoyeux, et al.
Addiction Biology|March 3, 2010
CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysisAmine Benyamina, Oussama Kebir, Lisa Blecha, et al.
Addiction Biology|March 12, 2008
Disposition of Delta tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoproteinLaurence Bonhomme-Faivre, Amine Benyamina, Michel Reynaud, et al.
La Revue Du Praticien|February 1, 2012
[Current strategies for treatment of alcohol problems]Henri-Jean Aubin, Amine Benyamina, Laurent Karila, et al.
La Revue Du Praticien|February 1, 2012
[How to deal with a patient who is not ready to abstinence?]Henri-Jeab Aubin, Amine Benyamina, Laurent Karila, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 28, 2006
Development and validation of a method for the quantitation of Delta9 tetrahydrocannabinol in human plasma by high performance liquid chromatography after solid-phase extractionChadi Abbara, Romain Galy, Amine Benyamina, et al.
Journal of Psychopharmacology (Oxford, England)|May 17, 2013
Quantitative damage-benefit evaluation of drug effects: major discrepancies between the general population, users and expertsMichel Reynaud, Amandine Luquiens, Henri-Jean Aubin, et al.
Pageof 11

Showing results (41-50 of 102) with videos related to

Sort By:
Pageof 11
La Revue Du Praticien|June 27, 2012
[Synthetic drugs: the new low-cost landscape of drugs]Laurent Karila, Aymeric Petit, Olivier Cottencin, et al.
La Revue Du Praticien|June 27, 2012
[Energy drinks: an unknown risk]Aymeric Petit, Fanny Levy, Michel Lejoyeux, et al.
The American Journal on Addictions|December 7, 2007
Intravenous zolpidem abuse: a case for serotonin depletionAmine Benyamina, Olivier Dublanchet, Laurent Karila, et al.
Presse Medicale (Paris, France : 1983)|February 17, 2012
[Addiction to cocaine: a risk factor for suicide?]Aymeric Petit, Michel Reynaud, Michel Lejoyeux, et al.
Addiction Biology|March 3, 2010
CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysisAmine Benyamina, Oussama Kebir, Lisa Blecha, et al.
Addiction Biology|March 12, 2008
Disposition of Delta tetrahydrocannabinol in CF1 mice deficient in mdr1a P-glycoproteinLaurence Bonhomme-Faivre, Amine Benyamina, Michel Reynaud, et al.
La Revue Du Praticien|February 1, 2012
[Current strategies for treatment of alcohol problems]Henri-Jean Aubin, Amine Benyamina, Laurent Karila, et al.
La Revue Du Praticien|February 1, 2012
[How to deal with a patient who is not ready to abstinence?]Henri-Jeab Aubin, Amine Benyamina, Laurent Karila, et al.
Journal of Pharmaceutical and Biomedical Analysis|February 28, 2006
Development and validation of a method for the quantitation of Delta9 tetrahydrocannabinol in human plasma by high performance liquid chromatography after solid-phase extractionChadi Abbara, Romain Galy, Amine Benyamina, et al.
Journal of Psychopharmacology (Oxford, England)|May 17, 2013
Quantitative damage-benefit evaluation of drug effects: major discrepancies between the general population, users and expertsMichel Reynaud, Amandine Luquiens, Henri-Jean Aubin, et al.
Pageof 11